Recap: Scholar Rock Holding Q1 Earnings
Scholar Rock Holding (NASDAQ:SRRK) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Scholar Rock Presents Data Analysis Of Multiple Efficacy Endpoints From The Apitegromab TOPAZ Phase 2 Trial At The 2022 European Paediatric Neurology Society Congress
Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that it is delivering a podium
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that moved stocks during the week.
HC Wainwright & Co. Initiates Coverage On Scholar Rock Holding with Buy Rating, Announces Price Target of $24
HC Wainwright & Co. analyst Michael King initiates coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Buy rating and announces Price Target of $24.